Clinical Trials Logo

Lesion clinical trials

View clinical trials related to Lesion.

Filter by:
  • None
  • Page 1

NCT ID: NCT03376971 Recruiting - Lung Cancer Clinical Trials

Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy

Start date: July 26, 2017
Phase: N/A
Study type: Interventional

This pilot early phase I trial studies how well real-time optical biopsy works in improving lung cancer diagnosis in patients undergoing lung biopsy. Real-time optical biopsy using confocal microscopy may improve the ability of physicians to diagnose lung cancer and accurately differentiate cancerous and benign lesions found during computed tomography screening.

NCT ID: NCT03202472 Completed - Breast Neoplasm Clinical Trials

Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery

Start date: August 3, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies radiofrequency technology in locating non-palpable breast lesions in patients undergoing surgery. Placing a miniature radiofrequency tag or microchip in the breast lesion before surgery and using a handheld device to guide doctors during surgery may improve surgical outcomes in patients with non-palpable breast lesions.

NCT ID: NCT00790283 Recruiting - Lesion Clinical Trials

Assessment of the Numen Stent With Evaluation in a Randomized Study

ANSWERS
Start date: September 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to Evaluate the Short-Term and Mid-Term Safety and Efficacy of the NUMEN Cobalt-Chromium coronary stent for the treatment of de novo lesions in native coronary arteries and compare it to the VISION/MINIVISION coronary stent

NCT ID: NCT00165620 Completed - Lesion Clinical Trials

A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease

Start date: November 2004
Phase: Phase 2
Study type: Interventional

To establish the optimum injection rate for E7337 (Iomeron 350) in dynamic CT in patients who have hepatic lesions.The primary endpoint for efficacy is the contrast enhancement effect in the early arterial phase, and the primary safety endpoints are warming sensation and vascular pain.